<p>在今天发布的一份报告中，来自富国银行的德里克·阿奇拉对 Alumis Inc.维持了买入评级，目标价为 49.00 美元。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以便做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
<p>阿奇拉覆盖医疗保健行业，关注的股票包括 Exelixis、Incyte 和 Rhythm Pharmaceuticals。根据 TipRanks 的数据，阿奇拉推荐股票的平均回报率为 20.9%，成功率为 53.85%。</p>
<p>市场普遍认为，Alumis Inc.的分析师共识评级为强烈买入，平均目标价为 39.71 美元。</p>

ALMS

<p>Wells Fargo 分析师 Derek Archila 重申了对 Alumis Inc. (ALMS) 的买入评级，目标价为 49.00 美元。该分析师的平均回报率为 20.9%，股票推荐的成功率为 53.85%。对 Alumis Inc. 的整体分析师共识为强烈买入，平均目标价为 39.71 美元</p>

<p>In a report released today, Derek Archila from Wells Fargo maintained a Buy rating on Alumis Inc., with a price target of $49.00.</p>
<div class="lb-trans"><p>在今天发布的一份报告中，来自富国银行的德里克·阿奇拉对 Alumis Inc.维持了买入评级，目标价为 49.00 美元。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以便做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
</div><p>Archila covers the Healthcare sector, focusing on stocks such as Exelixis, Incyte, and Rhythm Pharmaceuticals. According to TipRanks, Archila has an average return of 20.9% and a 53.85% success rate on recommended stocks.</p>
<div class="lb-trans"><p>阿奇拉覆盖医疗保健行业，关注的股票包括 Exelixis、Incyte 和 Rhythm Pharmaceuticals。根据 TipRanks 的数据，阿奇拉推荐股票的平均回报率为 20.9%，成功率为 53.85%。</p>
</div><p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for Alumis Inc. with a $39.71 average price target.</p>
<div class="lb-trans"><p>市场普遍认为，Alumis Inc.的分析师共识评级为强烈买入，平均目标价为 39.71 美元。</p>
</div>

Wells Fargo Sticks to Their Buy Rating for Alumis Inc. (ALMS)

Tip Ranks

Alumis

富国银行

伊克力西斯

因塞特医疗

Rhythm Pharma

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

富国银行维持对 Alumis Inc.（ALMS）的买入评级